UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

(Rule 13d-102)

 

Information Statement Pursuant to Rules 13d-1

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

 

BioTelemetry, Inc.**

(Name of Issuer)

Common Stock, $0.001 Par Value

(Title of Class of Securities)

090672106**

(CUSIP Number)

December 31, 2013

Date of Event Which Requires Filing of the Statement

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

**  On July 31, 2013, BioTelemetry, Inc. replaced CardioNet as the publicly-held corporation, continuing to trade on NASDAQ under the symbol “BEAT” but with a new CUSIP number. Existing shares of CardioNet common stock were converted automatically into shares of BioTelemetry Common Stock, with holders owning the same number of shares of BioTelemetry Common Stock as they previously owned CardioNet common stock, and each holder’s shares representing the same ownership percentage of BioTelemetry as they did CardioNet.

 



 

CUSIP No. 090672106

13G

 

 

 

1.

Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person

Trigran Investments, L.P.

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

x

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Illinois limited partnership

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
0

 

6.

Shared Voting Power
0 shares of common stock

 

7.

Sole Dispositive Power
0

 

8.

Shared Dispositive Power
0 shares of common stock

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
0 shares of common stock

 

 

10.

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

11.

Percent of Class Represented by Amount in Row (9)
0.0% as of December 31, 2013 (based on 25,755,353 shares of Common Stock issued and outstanding per BioTelemetry, Inc. Form 10-Q dated November 6, 2013).

 

 

12.

Type of Reporting Person
PN

 

2



 

CUSIP No. 090672106

13G

 

 

Item 1(a)

Name of Issuer:
BioTelemetry, Inc.

Item 1(b)

Address of Issuer’s Principal Executive Offices:
227 Washington Street

Conshohocken, Pennsylvania 19428

 

Item 2(a)

Name of Person Filing

Item 2(b)

Address of Principal Business Office

Item 2(c)

Citizenship
Trigran Investments, L.P.

630 Dundee Road, Suite 230

Northbrook, IL 60062

Illinois limited partnership

         2(d)

Title of Class of Securities:
Common Stock, $0.001 Par Value

         2(e)

CUSIP Number:
090672106

 

Item 3

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

(a)

o

Broker or dealer registered under section 15 of the Exchange Act;

 

(b)

o

Bank as defined in section 3(a)(6) of the Exchange Act;

 

(c)

o

Insurance company as defined in section 3(a)(19) of the Exchange Act;

 

(d)

o

Investment company registered under section 8 of the Investment Company Act;

 

(e)

o

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

 

(f)

o

An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

 

(g)

o

A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

 

(h)

o

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

 

(i)

o

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act;

 

(j)

o

A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);

 

(k)

o

Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:____________________________

 

If this statement is filed pursuant to Rule 13d-1(c), check this box. x

 

3



 

CUSIP No. 090672106

13G

 

 

Item 4

Ownership:

 

 

(a)

Amount beneficially owned:   

Incorporated by reference to Item 9 of the cover page.

 

(b)

Percent of class:   

Incorporated by reference to Item 11 of the cover page.

 

(c)

Number of shares as to which such person has:

 

 

 

(i)

Sole power to vote or to direct the vote:

Incorporated by reference to Item 5 of the cover page.

 

 

(ii)

Shared power to vote or to direct the vote:

Incorporated by reference to Item 6 of the cover page.

 

 

(iii)

Sole power to dispose or to direct the disposition of:

Incorporated by reference to Item 7 of the cover page.

 

 

(iv)

Shared power to dispose or to direct the disposition of:

Incorporated by reference to Item 8 of the cover page.

 

Item 5

Ownership of Five Percent or Less of a Class:

As of the date hereof, Trigran Investments, L.P. has ceased to be the beneficial owner of more than 5 percent of the class of securities.

 

Item 6

Ownership of More than Five Percent on Behalf of Another Person:

 

Not Applicable.

 

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

 

Not Applicable.

 

Item 8

Identification and Classification of Members of the Group:

 

Not Applicable.

 

Item 9

Notice of Dissolution of Group:

 

Not Applicable.

 

4



 

CUSIP No. 090672106

13G

 

 

Item 10

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 

Dated this 14th day of February, 2014

 

 

TRIGRAN INVESTMENTS, L.P.

 

By:

/s/ Lawrence A. Oberman

 

Name:

Lawrence A. Oberman

 

Title:

Executive Vice President and Director of Trigran Investments, Inc.,

 

 

the General Partner of Trigran Investments, L.P.

 

 

5